Glenn W Novotny

Glenn was most recently the CEO of Central Garden & Pet, (NASDAQ-CENT), with sales of $1.7 billion. He worked at Central for 17 years as President and Chief Operating Officer from 1990 to 2003 and CEO from 2003 through 2007. Glenn was instrumental in taking the company public in 1993 and growing it from annual sales of $200 million to $1.7 billion through organic growth and over 40 acquisitions to consolidate the pet and garden supplies industries in the US and Europe. He also worked at Weyerhaeuser Corporation from 1970 to 1990 in a variety of operating, strategic planning, sales, and executive management roles. He served as CEO of Weyerhaeuser Garden Supply from 1988 to 1990. Glenn has served on both public and private boards and also had significant entrepreneurial experiences in his career. Glenn has represented THP on the boards of AngioScore (acquired by Spectranetics), Freedom Innovations (acquired by Health Evolution Partners), Confirma (acquired by Merge) and NEXUS Biosystems (acquired by Brooks Automation). Glenn received a BA from Chadron State College in Nebraska and graduated from the Harvard Business School Executive Management Program.